Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 September 2019 | Story Ruan Bruwer | Photo Varsity Sports
Netball
Jana Scholtz, goal defender and playing in her first year as a regular starter, has been a solid performer for the Kovsie netball team in Varsity Netball.

The building blocks are starting to form a solid basis from where Kovsies can launch an attack to defend the Varsity Netball title they won in 2018. This is according to Karin Venter, one of the team’s assistant coaches.

After losing their first encounter to Tuks, they registered wins over the University of Johannesburg, Tshwane University of Technology, and the North-West University. The match against the Maties in Bloemfontein on 23 September 2019 – the last in the group stage, should determine which of the two teams will book a home semi-final along with Tuks.

“Yes, that is the crucial one,” said Venter, the team’s defensive coach. Her counterpart at the Maties is Adéle Niemand, with whom Venter combined as defenders at Kovsies for several matches in the mid-2000s. Apart from the Maties, the women of the University of the Free State still have to face the Madibaz and the University of the Western Cape (both in Pretoria on 15 and 16 September 2019).

“The combinations are starting to form a unit and our confidence is on the increase. Now we are looking for consistency in our performances.”

According to Venter, they were hit hard by goalkeeper Ané Retief’s injury, which kept her out of the first two matches. This meant that they had to start against Tuks with a first-year student, Chanel Vrey.

“It was tough, but I’m impressed with the way in which she, Ancia Pienaar, and Jana Scholtz – who are all youngsters – stepped up.”

Venter is responsible for the analyses and recons to assist players.

“The programme we are using provides us with all the required footage. You can make notes on it and send these clips to players, which means you don’t have to sit next to a player to explain something. We also provide them with notes and sketches of opponents’ playing patterns, which they must work through as part of their preparation.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept